Long-term follow-up of well-treated nephropathic cystinosis patients

Area of Science:

• Nephrology
• Genetics
• Pediatrics

Background:

• Nephropathic cystinosis is a rare, autosomal recessive lysosomal storage disease.
• It leads to the accumulation of cystine in various organs, particularly the kidneys.
• Early diagnosis and treatment are vital to prevent severe complications.

Observation:

• Two siblings diagnosed with nephropathic cystinosis received cysteamine treatment.
• Treatment initiation occurred at 20 months and 2 months of age for the elder and younger sibling, respectively.
• The siblings are now 15 and 8 years old.

Findings:

• Both siblings demonstrated excellent clinical outcomes.
• Glomerular filtration rates (GFR) were preserved at 78 mL/min/1.73m² and 105 mL/min/1.73m².
• Sustained renal function indicates treatment efficacy.

Implications:

• This case series underscores the critical importance of early diagnosis of nephropathic cystinosis.
• Diligent and timely cysteamine therapy can significantly improve long-term patient prognosis.
• Highlights the benefits of early intervention in rare genetic kidney diseases.